Converting habits of antibiotic prescribing for respiratory tract infections in German primary care – the cluster-randomized controlled CHANGE-2 trial

Abstract

BackgroundWith an average prescription rate of 50%, in German primary care antibiotics are still too frequently prescribed for respiratory tract infections. The over-prescription of antibiotics is often explained by perceived patient pressure and fears of a complicated disease progression. The CHANGE-2 trial will test the effectiveness of two interventions to reduce the rate of inappropriate antibiotic prescriptions for adults and children suffering from respiratory tract infections in German primary care.Methods/DesignThe study is a three-arm cluster-randomized controlled trial that measures antibiotic prescription rates over three successive winter periods and reverts to administrative data of the German statutory health insurance company AOK. More than 30,000 patients in two regions of Germany, who visit their general practitioner or pediatrician for respiratory tract infections will be included. Interventions are: A) communication training for general practitioners and pediatricians and B) intervention A plus point-of-care testing. Both interventions are tested against usual care. Outcome measure is the physicians’ antibiotic prescription rate for respiratory tract infections derived from data of the health insurance company AOK. Secondary outcomes include reconsultation rate, complications, and hospital admissions.DiscussionMajor aim of the study is to improve the process of decision-making and to ensure that patients who are likely to benefit from antibiotics are treated accordingly. Our approach is simple to implement and might be used rapidly among general practitioners and pediatricians. We expect the results of this trial to have major impact on antibiotic prescription strategies and practices in Germany, both among general practitioners and pediatricians.Trial registrationThe study is registered at the Current Controlled Trials Ltd (ISRCTN01559032)

Prescribing pattern of antibiotics in the department of pediatrics in a tertiary care medical college hospital in Northern India

“…16 Thus, more information about generic drugs and more research in the field of pediatric pharmacology are needed for increasing generic medicine prescription rate. 17 The average cost incurred per patient was Rs 3338. Beta lactams followed by aminoglycosides accounted for the maximal cost of the antimicrobials.…”

“…19 This would be best articulated through preparation and circulation of standard treatment guidelines (STG) which is the ultimate goal of our study.…”

Inventory of antibiotic stewardship programs in general practice in France and abroad

“…The Creactive protein point-of-care testing (CRP POCT) is commonly used in Scandinavian countries and Switzerland [53], and begins to be used in the Netherlands [54,55] and Germany [56,57]. This rapid test provides CRP blood levels in 2 minutes in the physician's office.…”

Efficacy and Safety of Morniflumate for the Treatment of Symptoms Associated with Soft Tissue Inflammation

“…11,23 Various strategies have been suggested to limit the use of antibiotics, including delayed prescription and the use of alternative drugs. [24][25][26][27] The search for other therapeutic options has also led to reconsidering the role of available and well characterized NSAIDs as alternatives to antibiotics for the symptomatic treatment of airway and other soft-tissue infections. 11,19 A literature review investigating the effectiveness of nonantibiotic treatments for acute sore throat found that NSAIDs were a valid alternative to antibiotics.…”

“…19,20,23 Respiratory tract infections, as well as other conditions involving soft-tissue inflammation, are a frequent cause of inappropriate prescribing of antibiotics. 11,[24][25][26][27] The benefits of antibiotic treatment for respiratory diseases and sore throat are modest in the absence of a bacterial infection. 11,23 Various strategies have been suggested to limit the use of antibiotics, including delayed prescription and the use of alternative drugs.…”